Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours

por Pili, R, Salumbides, B, Zhao, M, Altiok, S, Qian, D, Zwiebel, J, Carducci, M A, Rudek, M A
Publicado 2012

High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives

por Janjetovic, Z, Brozyna, A A, Tuckey, R C, Kim, T-K, Nguyen, M N, Jozwicki, W, Pfeffer, S R, Pfeffer, L M, Slominski, A T
Publicado 2011

Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients

por Kolk, A, Jubitz, N, Mengele, K, Mantwill, K, Bissinger, O, Schmitt, M, Kremer, M, Holm, P S
Publicado 2011

PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer

por Memon, A A, Weber, B, Winterdahl, M, Jakobsen, S, Meldgaard, P, Madsen, H H T, Keiding, S, Nexo, E, Sorensen, B S
Publicado 2011

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer

por Jehn, C F, Böning, L, Kröning, H, Possinger, K, Lüftner, D
Publicado 2012

Combined effect of low-penetrant SNPs on breast cancer risk

por Harlid, S, Ivarsson, M I L, Butt, S, Grzybowska, E, Eyfjörd, J E, Lenner, P, Försti, A, Hemminki, K, Manjer, J, Dillner, J, Carlson, J
Publicado 2012

Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection

por Clifford, G M, Lise, M, Franceschi, S, Egger, M, Bouchardy, C, Korol, D, Levi, F, Ess, S, Jundt, G, Wandeler, G, Fehr, J, Schmid, P, Battegay, M, Bernasconi, E, Cavassini, M, Calmy, A, Keiser, O, Schöni-Affolter, F
Publicado 2012

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of pa...

por Souglakos, J, Ziras, N, Kakolyris, S, Boukovinas, I, Kentepozidis, N, Makrantonakis, P, Xynogalos, S, Christophyllakis, Ch, Kouroussis, Ch, Vamvakas, L, Georgoulias, V, Polyzos, A
Publicado 2012

Meat consumption and the risk of incident distal colon and rectal adenoma

por Ferrucci, L M, Sinha, R, Huang, W-Y, Berndt, S I, Katki, H A, Schoen, R E, Hayes, R B, Cross, A J
Publicado 2012

Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer

por Ettl, T, Baader, K, Stiegler, C, Müller, M, Agaimy, A, Zenk, J, Kühnel, T, Gosau, M, Zeitler, K, Schwarz, S, Brockhoff, G
Publicado 2012

First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

por Arrieta, Ó, Medina, L A, Estrada-Lobato, E, Hernández-Pedro, N, Villanueva-Rodríguez, G, Martínez-Barrera, L, Macedo, E O, López-Rodríguez, V, Motola-Kuba, D, Corona-Cruz, J F
Publicado 2012

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide

por Young, R J, Tin, A W, Brown, N J, Jitlal, M, Lee, S M, Woll, P J
Publicado 2012

The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers

por Atherly, A J, Camidge, D R
Publicado 2012

Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer

por Peate, M, Meiser, B, Cheah, B C, Saunders, C, Butow, P, Thewes, B, Hart, R, Phillips, K-A, Hickey, M, Friedlander, M
Publicado 2012

The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models

por Holt, S V, Logié, A, Odedra, R, Heier, A, Heaton, S P, Alferez, D, Davies, B R, Wilkinson, R W, Smith, P D
Publicado 2012

Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma

por Nordenstedt, H, Mattsson, F, El-Serag, H, Lagergren, J
Publicado 2012

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification

por Betof, A S, Rabbani, Z N, Hardee, M E, Kim, S J, Broadwater, G, Bentley, R C, Snyder, S A, Vujaskovic, Z, Oosterwijk, E, Harris, L N, Horton, J K, Dewhirst, M W, Blackwell, K L
Publicado 2012

Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer

por Klinkhammer-Schalke, M, Koller, M, Steinger, B, Ehret, C, Ernst, B, Wyatt, J C, Hofstädter, F, Lorenz, W
Publicado 2012

Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study

por Martin, N K, Robey, I F, Gaffney, E A, Gillies, R J, Gatenby, R A, Maini, P K
Publicado 2012

Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of c...

por Vogl, T J, Jost, A, Nour-Eldin, N A, Mack, M G, Zangos, S, Naguib, N N N
Publicado 2012